Kobayashi et al. [36] have also showed that zinc supplementation with polaprezinc reduced serum ferritin levels, required ESA dosage, and erythropoietin responsiveness index, although it didn’t change anemic parameters (RBC and Hb) in HD patients. The gene discussed is GSTM1; the disease is Huntington disease.